Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004
Neurosyphillis in the Modern Era
JNNP 75:1727-1730, Timmermans,M. &Carr,J., 2004
Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004
Mixed Dementia, Emerging Concepts and Therapeutic Implications
JAMA 292:2901-2908, Langa,K.M.,et al, 2004
Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Infratentorial Lesions Predict Long-term Disability in Patients with Initial Findings Suggestive of Multiple Sclerosis
Arch Neurol 61:217-221, Minneboo,A.,et al, 2004
Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004
Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment
AJNR 25:195-200,167, Ragin,A.B.,et al, 2004
Comparison of Different MRI Brain Atrophy Rate Measures with Clinical Disease Progression in AD
Neurol 62:591-600, Jack, Jr.,C.R.,et al, 2004
Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004
Estimating Prognosis for Nursing Home Residents with Advanced Dementia
JAMA 291:2734-2740, Mitchell,S.L.,et al, 2004
Dementia After Stroke
Stroke 35:1264-1269, Ivan,C.S.,et al, 2004
Balint Syndrome Due to Creutzfeldt-Jakob Disease
Neurol 63:395, Ances,B.M.,et al, 2004
Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004
Most Cases of Dementia with Hippocampal Sclerosis May Represent Frontotemporal Dementia
Neurol 63:538-542, Hatanpaa,K.J.,et al, 2004
Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004
Efficacy of Donepezil in Mild Cognitive Impairment
Neurol 63:651-657, Salloway,S.,et al, 2004
Diabetes, Impaired Fasting Glucose, and Development of Cognitive Impariment in Older Women
Neurol 63:658-663, Yaffe,K.,et al, 2004
Clinicopath Conf, Multiple-System Atrophy
NEJM 351:912-921, Case 27-2004, 2004
Neurologic Impairment 10 Years After Optic Neuritis
Arch Neurol 61:1386-1389, Optic Neuritis Study Group, 2004
The Natural History of Recurrent Optic Neuritis
Arch Neurol 61:1401-1405, Pirko,I.,et al, 2004
Atypical Antipsychotic Drugs in the Treatment of Behavioural and Psychological Symptoms of Dementia: Systematic Review
BMJ 329:75-78, Lee,P.E.,et al, 2004
Progressive Dementia after First-Ever Stroke, A Community-Based Follow-up Study
Neurol 63:785-792, Srikanth,V.K.,et al, 2004
Higher Frequency of Dementia in Older HIV-1 Individuals, The Hawaii Aging with HIV-1 Cohort
Neurol 63:822-827, Valcour,V.,et al, 2004
Driver Route-Following and Safety Errors in Early Alzheimer Disease
Neurol 63:832-837, Uc,E.Y.,et al, 2004
Walking and Dementia in Physically Capable Elderly Men
JAMA 292:1447-1453, Abbott,R.D.,et al, 2004
Diffusion-Weighted and Conventional MR Imaging Findings of Neuroaxonal Dystrophy
AJNR 25:1269-1273, Sener,R.N., 2004
Bovine Spongiform Encephalopathy in the United States - An Epidemiologist's View
NEJM 350:539-542, Donnelly,C.A., 2004
Transmissible Spongiform Encephalopathies
Lancet 363:51-61, Collins,S.J.,et al, 2004
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Dementia with Lewy Bodies
Lancet 362:1689-1690, Wilcock,G.K., 2003
Efficacy and Tolerability of Donepezil in Vascular Dementia
Stroke 34:2323-2332, Black,S.,et al, 2003
Low Blood Pressure and Risk of Dementia in the Kungsholmen Project
Arch Neurol 60:223-228, Qiu,C.,et al, 2003
Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia
Stroke 34:1907-1912, van Straaten,E.C.W.,et al, 2003
14-3-3 Protein in the CSF of Patients with Rapidly Progressive Dementia
Neurol 61:354-357, Huang,N.,et al, 2003
Donepezil in Vascular Dementia
Neurol 61:479-486,429, Helme,R.,et al, 2003
Early Alzheimer's Disease
NEJM 349:1056-1063, Kawas,C.H., 2003
Learning Disability
Lancet 362:811-821, Gillberg,C.&Soderstrom,H., 2003
Clinical Features and Neuropathology of Autosomal Dominant Spinocerebellar Ataxia (SCA17)
Ann Neurol 43:367-375, Rolfs,A.,et al, 2003
Vascular Syndromes of the Thalamus
Stroke 34:2264-2278, Schumahmann,J.D., 2003
End-of-Life Care and the Effects of Bereavement on Family Caregivers of Persons with Dementia
NEJM 349:1936-1942,1891, Schulz,R.,et al, 2003
Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003
Mitochondrial Respiratory-Chain Diseases
NEJM 348:2656-2668, DiMauro,S. &Schon,E.A., 2003
Leisure Activities and the Risk of Dementia in the Elderly
NEJM 348:2508-2516, Verghese,J.,et al, 2003
Neurologic Manifestations of Vitamin B12 Deficiency
NEJM 348:2208, Scherer,K., 2003
Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
NEJM 348:1215-1222, 1277, Vermeer,S.E.,et al, 2003
Intellectual Impairment in children with Blood Lead Concentrations Below 10 ug per Deciliter
NEJM 348:1517-1526,1515, Canfield,R.L.,et al, 2003